UiPath, Inc.
Latest List Rankings
Current Synopsis
UiPath is the software optionality name, not a proven AI hypergrowth winner. The credible case is operating leverage plus a possible agentic-automation re-rating if enterprises use UiPath as an orchestration layer for AI agents, robots, and people. The restraint: current ARR growth still has to reaccelerate before the 5x case deserves more than turnaround/optionality status.
Current Pillar Scores
2x model: valuation-to-growth is 93.5/100 with convexity 54.0/100; that means the score is rewarding growth-adjusted asymmetry, not cheapness in isolation. 5x model: market-cap asymmetry is 95.0/100 at roughly $6.1B current market cap, which is why size matters more here than business quality alone.
The earnings/growth score is driven by reported fundamentals, not narrative. revenue growth 17.3%, gross margin 83.0%, operating margin 7.3%, profit margin 19.6%, FCF margin 31.2%. Component support: growth acceleration 49.1, survivability 93.8.
PATH's catalyst is the possibility that automation becomes the control layer for enterprise AI agents. That is a compelling narrative, but the page needs to be honest that the current growth profile is not yet 5x-grade. The thesis depends on reacceleration and product relevance in an AI-native workflow stack.
July technical setup is 28/100 from refreshed price history: 20-day return -5.2%, 60-day return 3.6%, 120-day return -35.3%, distance from 52-week high -41.8%. Above 50dma: true; above 200dma: false.
For July this pillar is better read as options/positioning confirmation, not social-media fluff. ATM implied volatility 70.1%, call/put OI 2.3, call/put volume 3.9, OTM call OI share 62.9%, short % float 31.8%, short ratio 4.6. Component support: options asymmetry 82.1, squeeze bonus 7.0.
The base Goldilox math is roughly $6.1B current market cap versus a $12.0B bull case, or about 1.97x. That supports the 2x thesis better than the 5x thesis. The 5x case requires a true AI-agent platform re-rating and visible growth acceleration.
Current Path to Target
A 2x requires ARR acceleration, better enterprise AI adoption, and evidence that UiPath can attach itself to agentic workflows rather than be displaced by them.
The 5x case is a stretch turnaround: UiPath would need to become a core enterprise orchestration layer for AI agents, with accelerating ARR and expanding margins. The current numbers do not prove that yet, so this should be framed as conditional upside.
Current Key Risk
The risk is that UiPath remains a slower-growth automation platform while AI agents commoditize pieces of the workflow stack. Without visible ARR acceleration, stronger net retention, or clear AI-native product traction, the 5x case remains more narrative than numbers.
Current Key Metrics
BRRR Appearance History
Current analysis stays canonical. This is the compact scoreboard of where the name has shown up across monthly BRRR lists.
Subscribe for monthly updates on this stock and the full rankings
Keep the latest thesis current, while the appearance history shows how conviction evolved over time.
Subscribe Free →